You are here: Industry Insights > Shingrix

News List

GlaxoSmithKline limits Shingrix orders, delays TV commercials amid 'unprecedented' demand fiercevaccines
June 26, 2018
GlaxoSmithKline's new shingles vaccine Shingrix quickly captured the market after winning FDA approval and a preferential recommendation from CDC vaccine advisers
Doctors worry Shingrix side effects will put patients off their second dose fiercevaccines
June 26, 2018
The CDC has urged people 50 and older to get GlaxoSmithKline's new shingles vaccine to protect against a notoriously painful condition.
GlaxoSmithKline boosted Shingrix educational efforts after seeing administration, storage errors in launch fiercepharma
June 06, 2018
Drug launches come with an array of challenges, and GlaxoSmithKline is experiencing that firsthand with its U.S. shingles vaccine rollout.
GSK’s Shingles Vaccine is Bright Spot in First Quarter of 2018 biospace
April 26, 2018
Despite strong sales of shingles vaccine Shingrix, GlaxoSmithKline reported its sales and earnings fell 2 percent in the first quarter of the year, largely due to...
Gardasil's growth led Merck's vaccine sales of $6.5B in 2017 as Zostavax struggles fiercepharma
February 07, 2018
Merck's vaccine business kept churning in 2017, generating sales of $6.5 billion and growing by 4.8% over the prior year.
GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect Shingrix fiercepharma
October 18, 2017
The Canadian approval covers people 50 years or older, as a prevention tool against the painful condition that's caused by latent varicella infection.

Previous page 1 2 3 Next page